Centerpulse Spine-Tech Broadens Pipeline To Include BMP Alternative
This article was originally published in The Gray Sheet
Executive Summary
Centerpulse's Spine-Tech division expects to market itsallogenic bone concentrate (ABC) as an alternative to bone morphogenic protein for spinal fusion during the second half of 2003
You may also be interested in...
Zimmer/Centerpulse Merger Would Build Minimally-Invasive Surgery Portfolio
Centerpulse's allogenic bone concentrate (ABC) would give Zimmer a spine fusion product to compete directly with Medtronic Sofamor Danek's InFuse bone graft/LT-CAGE lumbar tapered fusion device
Zimmer/Centerpulse Merger Would Build Minimally-Invasive Surgery Portfolio
Centerpulse's allogenic bone concentrate (ABC) would give Zimmer a spine fusion product to compete directly with Medtronic Sofamor Danek's InFuse bone graft/LT-CAGE lumbar tapered fusion device
Centerpulse Biologics Unit To Be Split Up Under Evolving Reorganization Plan
Centerpulse's Biologics and Strategic Development Division activities will be integrated into the firm's remaining operating units under a reorganization plan that also includes dismissal of CEO Stephan Rietiker